Leveraging a novel protein tagging strategy offers new route to cancer treatment
In a pioneering collaboration with AbbVie, Northwestern researchers have discovered a new way to potentially treat cancer by ...
News Medical on MSN2d
Study identifies vitamin E succinate as key to tumor growth control
High levels of fat mass and obesity-associated protein (FTO) have been linked to increased tumor growth and resistance to ...
Vitamin E succinate shown to control tumor growth and enhance immunotherapy effects
High levels of fat mass and obesity-associated protein (FTO) have been linked to increased tumor growth and resistance to ...
technologynetworks1y
Expanding the PROTACtable Genome Universe of E3 Ligases
However, the power of PROTACs lies in the engagement of E3 ligases, and currently, less than two percent of the vast array of E3 ligases in the human genome have been explored in the TPD field. Dr.
Hosted on MSN10mon
Outrun Therapeutics announces launch with $10m seed funding
UK-based biotech company Outrun Therapeutics has announced its launch with a $10m seed investment to advance its protein stabilisation pipeline focused on E3 ligase inhibitors. The financial ...
Medindia19h
Vitamin E Succinate Enhances Cancer Immunotherapy and Slows Tumor Growth
Vitamin E succinate has been found to inhibit tumor growth and enhance the effectiveness of immunotherapy by targeting ...
Yahoo Finance1mon
Outrun Therapeutics expands leadership team with appointment of Matthew Fyfe as Chief Scientific Officer
DUNDEE, Scotland, Jan. 13, 2025 /PRNewswire/ -- Outrun Therapeutics ("Outrun"), the E3 ligase inhibitor and protein stabilisation specialist, today announces the appointment of Matthew Fyfe as its ...
Promising Clinical Developments and Strategic Collaborations Justify Buy Rating for Nurix Therapeutics
Nurix Therapeutics (NRIX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jeet ...